文献速递泌尿男性生殖肿瘤

配对原发肾细胞癌与转移灶的差异基因表达谱揭示细胞外基质基因上调

Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes.
PubMed 文献 · Ann Oncol · 2017-01-01

该研究采用两阶段设计,首先用Affymetrix芯片比较15对配对原发肾细胞癌(14例透明细胞癌、1例乳头状癌)与肺转移灶的基因表达,随后用定制NanoString panel在114例透明细胞癌独立队列中验证7个候选基因,并利用癌症基因组图谱(TCGA)数据评估其与生存的关联。研究识别并验证了7个细胞外基质(ECM)相关基因的上调,其中CEACAM6和LUM在原发透明细胞癌中与无转移生存和总生存显著相关(P < 0.01),提示ECM基因上调可能是透明细胞癌发生内脏、骨和软组织转移的关键分子事件。

要点

  • 配对原发与转移性透明细胞癌的基因表达谱存在差异,转移灶中细胞外基质基因上调。
  • 识别并验证7个ECM相关基因上调:DCN、SLIT2、LUM、LAMA2、ADAMTS12、CEACAM6和LMO3。
  • 原发透明细胞癌中CEACAM6和LUM与无转移生存和总生存显著相关(P < 0.01)。

核心结论

  • 研究采用迄今最大规模的配对原发与转移性透明细胞癌基因表达谱,识别出转移灶中细胞外基质基因上调。
  • 作者认为细胞外基质基因上调是透明细胞癌发生内脏、骨和软组织转移的关键分子事件。

研究设计与样本

  • 两阶段设计:第一阶段用Affymetrix芯片比较15对配对原发肾细胞癌(14例透明细胞癌、1例乳头状癌)与肺转移灶的基因表达。
  • 第二阶段用定制NanoString panel在114例透明细胞癌独立队列中验证7个候选基因。
  • 采用混合效应线性模型评估差异基因表达,纳入患者随机效应以处理配对数据。
  • 利用癌症基因组图谱(TCGA)数据评估原发透明细胞癌中基因与无转移生存和总生存的关联。

主要发现

  • 识别并验证7个功能上参与细胞外基质形成的基因上调:DCN、SLIT2、LUM、LAMA2、ADAMTS12、CEACAM6和LMO3。
  • 在原发透明细胞癌中,CEACAM6和LUM与无转移生存和总生存显著相关(P < 0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The majority of renal cell carcinoma (RCC) studies analyze primary tumors, and the corresponding results are extrapolated to metastatic RCC tumors. However, it is unknown if gene expression profiles from primary RCC tumors differs from patient-matched metastatic tumors. Thus, we sought to identify differentially expressed genes between patient-matched primary and metastatic RCC tumors in order to understand the molecular mechanisms underlying the development of RCC metastases. PATIENTS AND METHODS: We compared gene expression profiles between patient-matched primary and metastatic RCC tumors using a two-stage design. First, we used Affymetrix microarrays on 15 pairs of primary RCC [14 clear cell RCC (ccRCC), 1 papillary] tumors and patient-matched pulmonary metastases. Second, we used a custom NanoString panel to validate seven candidate genes in an independent cohort of 114 ccRCC patients. Differential gene expression was evaluated using a mixed effect linear model; a random effect denoting patient was included to account for the paired data. Third, The Cancer Genome Atlas (TCGA) data were used to evaluate associations with metastasis-free and overall survival in primary ccRCC tumors. RESULTS: We identified and validated up regulation of seven genes functionally involved in the formation of the extracellular matrix (ECM): DCN, SLIT2, LUM, LAMA2, ADAMTS12, CEACAM6 and LMO3. In primary ccRCC, CEACAM6 and LUM were significantly associated with metastasis-free and overall survival (P < 0.01). CONCLUSIONS: We evaluated gene expression profiles using the largest set to date, to our knowledge, of patient-matched primary and metastatic ccRCC tumors and identified up regulation of ECM genes in metastases. Our study implicates up regulation of ECM genes as a critical molecular event leading to visceral, bone and soft tissue metastases in ccRCC.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Ho TH, Serie DJ, Parasramka M, et al. Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes. Ann Oncol. 2017. PMID: 27993815. doi:10.1093/annonc/mdw652

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。